Acadian Asset Management
BNGO icon

Acadian Asset Management’s Bionano Genomics BNGO Stock Holding History

Acadian Asset Management’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1
Closed -$2K – 1955
2018
Q4 		$2K Buy
+1
New +$3.98K ﹤0.01% 1692

Other funds holding BNGO

SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Acadian Asset Management's BNGO Position: Q1 2019 in Review

Acadian Asset Management sold out of Bionano Genomics (BNGO) in Q1 2019, closing a stake of 1 share — an estimated $2K sold.

Acadian Asset Management first reported a position in BNGO in Q4 2018 and held it in 1 quarter. The position peaked at $2K in Q4 2018. 10 funds tracked by Wall St. Rank hold BNGO as of Q1 2019.

  • Acadian Asset Management reported no remaining Bionano Genomics position as of Q1 2019 after selling out during the quarter.
  • Acadian Asset Management sold 1 Bionano Genomics share in Q1 2019, an estimated $2K.
  • Acadian Asset Management first reported a position in Bionano Genomics in Q4 2018 and held it in 1 quarter.
  • Acadian Asset Management's Bionano Genomics position peaked at $2K in Q4 2018.
  • 10 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2019.

Based on Acadian Asset Management's 13F filing for Q1 2019, filed 9 May 2019.